U.S. STOCKS Danimer Scientific, Constellation Energy, Elevai Labs
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
U.S. stock index futures were muted on Monday, as investors awaited comments from a bunch of policymakers and data to gauge the outlook for interest rates and the economy's health, days after the Federal Reserve commenced its easing cycle. .N
At 9:00 ET, Dow e-minis 1YMc1 were up 0.05% at 42,466. S&P 500 e-minis ESc1 were up 0.22% at 5,774.75, while Nasdaq 100 e-minis NQc1 were up 0.31% at 20,090.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** Biohaven Ltd <BHVN.N>, up 17.3%
** Danimer Scientific <DNMR.N>, up 11.4%
** ZipRecruiter <ZIP.N>, up 9.3%
The top three NYSE percentage losers premarket .PRPL.NQ:
** Zevia <ZVIA.K>, down 16%
** Miniso Group Depositary Shares <MNSO.K>, down 12.5%
** Olo <OLO>, down 10.3%
The top Nasdaq percentage gainers premarket .PRPG.O:
** Nuvve Holding Corp <NVVE.O>, up 86.7%
The top Nasdaq percentage losers premarket .PRPL.O:
** Elevai Labs Inc <ELAB.O>, down 59.7%
** United Rentals Inc URI.N: up 0.5% premarket
BUZZ - JP Morgan lifts United Rentals PT on long-term growth potential nL4N3L50JY
** Moody's Corp MCO.N: down 0.7% premarket
BUZZ - Dips after Raymond James downgrades to 'underperform' nL4N3KZ118
** Constellation Energy Corp CEG.O: up 3.1% premarket
BUZZ - Jefferies raises PT on Constellation Energy nL4N3L10SW
** Coinbase Global Inc COIN.O: up 1.1% premarket ** Riot Platforms Inc RIOT.O: up 0.6% premarket
** Hut 8 Mining Corp HUT.O: up 0.5% premarket
BUZZ - Crypto stocks rise on bitcoin strength nL4N3L50NG
** Keros Therapeutics Inc KROS.O: up 5.6% premarket
BUZZ - Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential nL4N3L50OA
** Ulta Beauty Inc ULTA.O: down 1.7% premarket
BUZZ - Falls after TD Cowen downgrades to 'hold' nL4N3L50OW
** Wheels up Experience Inc UP.N: up 4.2% premarket
BUZZ - Climbs as investors agree to 1-year lock-up extension nL4N3L50Q7
** Biohaven Ltd BHVN.N: up 17.3% premarket
BUZZ - Gains as inherited disease drug meets main goal in trial nL4N3L50QL
** Microsoft Corp MSFT.O: down 0.4% premarket
BUZZ - Edges down; DA Davidson cuts rating to 'neutral' nL4N3L50QA
** Analog Devices Inc ADI.O: down 1.1% premarket
** Microchip Technology Inc MCHP.O: down 1.1% premarket
BUZZ - Fall after Truist downgrades to 'hold' nL4N3L50QD
** Ideaya Biosciences Inc IDYA.O: up 7.2% premarket
BUZZ - Climbs on positive mid-stage trial for eye cancer drug nL4N3L50QZ
** General Motors Co GM.N: down 3.1% premarket
BUZZ - Falls after Bernstein's rating cut on earnings challenges nL4N3L50QI
** Uranium Energy Corp UEC.N: up 2.2% premarket
BUZZ - Up after $175 mln deal for Rio Tinto's Wyoming uranium assets nL4N3L50T0
(Compiled by Rajarshi Roy and Vedant Vinayak Vichare)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
